(Q37104767)

18 August 2017

Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy (English)

1 reference

Vassiliki Papadimitrakopoulou

18 August 2017

1 reference

1

object named as

Vassiliki A Papadimitrakopoulou

1 reference

18 August 2017

10

Waun Ki Hong

1 reference

18 August 2017

11

Scott M Lippman

1 reference

18 August 2017

J Jack Lee

2

1 reference

18 August 2017

William N William

3

1 reference

18 August 2017

Jack W Martin

4

1 reference

18 August 2017

Margaret Thomas

5

1 reference

18 August 2017

Edward S Kim

6

1 reference

18 August 2017

Fadlo R Khuri

7

1 reference

18 August 2017

Dong M Shin

8

1 reference

18 August 2017

Lei Feng

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

15 December 2008

1 reference

Journal of Clinical Oncology

18 August 2017

1 reference

18 August 2017

27

1 reference

18 August 2017

4

1 reference

18 August 2017

599-604

1 reference

The convergent development of molecular-targeted drugs for cancer treatment and prevention

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

13-cis-retinoic acid in the treatment of oral leukoplakia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Predicting cancer development in oral leukoplakia: ten years of translational research

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

"Proving the null hypothesis" in clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Sample size graphs for "proving the null hypothesis".

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Response of oral leukoplakias to the administration of vitamin A

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Sample size requirements for evaluating a conservative therapy.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2645856

Oral leukoplakia and malignant transformation. A follow-up study of 257 patients

3 September 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up

1 reference

PubMed

12 December 2020

Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.17.1850

1 reference

18 August 2017

1 reference

18 August 2017

1 reference